Literature DB >> 17999786

Exhaled inflammatory markers in aspirin-induced asthma syndrome.

Giovanna E Carpagnano1, Onofrio Resta, Matteo Gelardi, Antonio Spanevello, Giuseppe Di Gioia, Tiziana Giliberti, Annarita Depalo, Maria P Foschino Barbaro.   

Abstract

BACKGROUND: Interleukin (IL)-4 and IL-6, respectively, markers of neutrophilic and eosinophilic inflammation, were analyzed in nasal and oral exhaled breath condensate to understand the inflammation of upper and lower airways in subjects with aspirin-induced asthma (AIA) syndrome, evaluating possible differences between AIA and the single pathological conditions included in AIA syndrome.
METHODS: Twelve patients with AIA, 17 patients with mild asthma (MA), 12 patients with nasal polyposis (NP), 11 patients with mild asthma + nasal polyposis (MA + NP), and 10 healthy subjects (HSs) were enrolled. Nasal and oral exhaled IL-4 and IL-6 were measured by enzyme immunoassay kit.
RESULTS: Higher levels of nasal and oral exhaled IL-4 and IL-6 were observed in AIA compared with MA, NP, MA + NP, and HSs. Moreover, a positive correlation was identified between nasal exhaled IL-4 and IL-6 and, respectively, the number of neutrophils and eosinophils and in nasal scraping.
CONCLUSION: The concentration of eosinophilic and neutrophilic markers in upper and lower airways of subjects with AIA syndrome is higher compared with HS and subjects with MA, NP, and MA + NP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17999786     DOI: 10.2500/ajr.2007.21.3066

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  3 in total

Review 1.  Exhaled Breath Condensate: Technical and Diagnostic Aspects.

Authors:  Efstathia M Konstantinidi; Andreas S Lappas; Anna S Tzortzi; Panagiotis K Behrakis
Journal:  ScientificWorldJournal       Date:  2015-05-27

Review 2.  Inflammatory Biomarkers in Exhaled Breath Condensate: A Systematic Review.

Authors:  Federica Ghelli; Marco Panizzolo; Giacomo Garzaro; Giulia Squillacioti; Valeria Bellisario; Nicoletta Colombi; Enrico Bergamaschi; Irina Guseva Canu; Roberto Bono
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

3.  Analysis of volatile compounds in exhaled breath condensate in patients with severe pulmonary arterial hypertension.

Authors:  J K Mansoor; Edward S Schelegle; Cristina E Davis; William F Walby; Weixiang Zhao; Alexander A Aksenov; Alberto Pasamontes; Jennifer Figueroa; Roblee Allen
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.